Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks

Apheresis is frequently used in MOGAD attacks. An early start as first-line therapy and concomitant disease-modifying therapy predict full attack recovery.

Authors

Institutions

Publication Details

Journal
Journal of Neurology Neurosurgery & Psychiatry
Published
2024-11-04
DOI
https://doi.org/10.1136/jnnp-2024-334863
Citations
17
Primary Topic
Peripheral Neuropathies and Disorders
Type
article
Field-Weighted Citation Impact
6.28

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks

Ana Beatriz Ayroza Galvão Ribeiro Gomes, Leila Husseini, Makbule Şenel, Carolin Schwake et al.
17 citations
Journal of Neurology Neurosurgery & Psychiatry
Peripheral Neuropathies and Disorders
6.28
article

Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks

Ana Beatriz Ayroza Galvão Ribeiro Gomes, Leila Husseini, Makbule Şenel, Carolin Schwake, Julian Reza Kretschmer, Clemens Gödel, Tania Kümpfel, Daria Tkachenko, Theodoros Ladopoulos, Patricia K. N. Schwarz, Brigitte Wildemann, Paulus Stefan Rommer, Refik Pul, Patrick Schindler, Marius Ringelstein, Judith Bellmann–Strobl, Joachim Havla, Friedemann Paul, Corinna Trebst, Ralf Gold, Vivien Häußler, Mirjam Korporal‐Kuhnke, Florian Then Bergh, Alexander Winkelmann, Martin W. Hümmert, Sven Jarius, Anne‐Katrin Pröbstel, Mosche Pompsch, Markus C. Kowarik, Nele Retzlaff, Daniel Engels, Ioannis Vardakas, Ilya Ayzenberg, Orhan Aktas, Ingo Kleiter, Martin S. Weber, Annette O. Walter, Markus Krämer
article en
17 citations

Abstract

Apheresis is frequently used in MOGAD attacks. An early start as first-line therapy and concomitant disease-modifying therapy predict full attack recovery.

Journal of Neurology Neurosurgery & PsychiatryVol. 96(7)
Universität Hamburg (DE), University of Basel (CH), Universität Ulm (DE), Max Delbrück Center (DE), Heidelberg University (DE), University Hospitals of the Ruhr-University of Bochum (DE), LMU Klinikum (DE), Medizinische Hochschule Hannover (DE), Humboldt-Universität zu Berlin (DE), Fraunhofer Institute for Translational Medicine and Pharmacology (DE), University Medical Center Hamburg-Eppendorf (DE), Universitätsmedizin Göttingen (DE), Herford Hospital (DE), St. Josef-Hospital (DE), Gemeinschaftskrankenhaus Herdecke (DE), Alfried Krupp Hospital (DE), Heinrich Heine University Düsseldorf (DE), University of Rostock (DE), University of Duisburg-Essen (DE), University of Göttingen (DE), Freie Universität Berlin (DE), Medical University of Vienna (AT), Charité - Universitätsmedizin Berlin (DE), University of Tübingen (DE), Ludwig-Maximilians-Universität München (DE), Ruhr University Bochum (DE), Leipzig University (DE)
National Multiple Sclerosis Society, Amgen, Bristol-Myers Squibb, Pfizer, AstraZeneca, GlaxoSmithKline, Roche, Sanofi, Biogen, Teva Pharmaceutical Industries, Alexion Pharmaceuticals, Celgene, Guthy-Jackson Charitable Foundation, CSL Behring, Amicus Therapeutics, Universitätsmedizin Göttingen, Horizon Therapeutics, Multiple Sclerosis Society, Bayer HealthCare, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Austrian Science Fund, Klaus Tschira Stiftung, Federalno Ministarstvo Obrazovanja i Nauke, Chugai Pharmaceutical
Good health and well-being
Openalex Percentile: Top 3%
Peripheral Neuropathies and Disorders
6.28
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.